Insulin degludec is superior to sitagliptin in improving glycaemic control in uncontrolled patients with type 2 diabetes on oral agents
Author
Rasmussen, S.
Dharmalingam, M.
Skjoth, T. V.
Garber, A. J.
Satman, I.
Philis-Tsimikas, A.
Del Prato, S.
Bhargava, A.
Metadata
Show full item recordCollections
- Makale [92796]